<bill session="118" type="h" number="5397" updated="2025-05-27T14:14:48Z">
  <state datetime="2023-12-06">REPORTED</state>
  <status>
    <unknown datetime="2023-12-06"/>
  </status>
  <introduced datetime="2023-09-12"/>
  <titles>
    <title type="display">Joe Fiandra Access to Home Infusion Act of 2023</title>
    <title type="short" as="introduced">Joe Fiandra Access to Home Infusion Act of 2023</title>
    <title type="official" as="introduced">To amend title XVIII of the Social Security Act to provide coverage of external infusion pumps and non-self-administrable home infusion drugs under the Medicare program.</title>
  </titles>
  <sponsor bioguide_id="F000466"/>
  <cosponsors>
    <cosponsor bioguide_id="C001126" joined="2024-05-23"/>
    <cosponsor bioguide_id="C001103" joined="2023-10-18"/>
    <cosponsor bioguide_id="D000628" joined="2023-09-12"/>
    <cosponsor bioguide_id="F000465" joined="2023-11-01"/>
    <cosponsor bioguide_id="H001090" joined="2024-04-02"/>
    <cosponsor bioguide_id="H001082" joined="2024-06-26"/>
    <cosponsor bioguide_id="K000376" joined="2024-05-24"/>
    <cosponsor bioguide_id="M001205" joined="2024-05-16"/>
    <cosponsor bioguide_id="P000616" joined="2024-09-23"/>
    <cosponsor bioguide_id="S001185" joined="2023-11-03"/>
    <cosponsor bioguide_id="S001172" joined="2024-05-07"/>
    <cosponsor bioguide_id="S001200" joined="2023-10-06"/>
  </cosponsors>
  <actions>
    <action datetime="2023-09-12">
      <text>Introduced in House</text>
    </action>
    <action datetime="2023-09-12" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2023-09-12">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2023-09-22">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2023-11-15">
      <text>Subcommittee Consideration and Mark-up Session Held</text>
    </action>
    <action datetime="2023-11-15">
      <text>Forwarded by Subcommittee to Full Committee in the Nature of a Substitute (Amended) by Voice Vote.</text>
    </action>
    <action datetime="2023-12-05">
      <text>Committee Consideration and Mark-up Session Held</text>
    </action>
    <action datetime="2023-12-06">
      <text>Committee Consideration and Mark-up Session Held</text>
    </action>
    <action datetime="2023-12-06" state="REPORTED">
      <text>Ordered to be Reported (Amended) by the Yeas and Nays: 46 - 0.</text>
    </action>
    <action datetime="2024-12-17">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referred To"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Markup By, Markup By, Referred To"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Consumer affairs"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Health care coverage and access"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Home and outpatient care"/>
    <term name="Medicare"/>
  </subjects>
  <amendments/>
</bill>
